Treatment options
Hi all,
Here is a discussion about prescribing decisions for high-risk MDS. Emerging therapies are Gemtuzumab (Pfizer’s Mylotarg), Clofarabine (Genzyme’s Clolar/Clofarex/Evoltra) and Vorinostat (Merck & Co.’s Zolinza). http://www.decisionresources.com/Pro...t?r=dbaspd3010 Kind regards Birgitta-A |
| All times are GMT -4. The time now is 09:47 PM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org